SE0004098D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0004098D0
SE0004098D0 SE0004098A SE0004098A SE0004098D0 SE 0004098 D0 SE0004098 D0 SE 0004098D0 SE 0004098 A SE0004098 A SE 0004098A SE 0004098 A SE0004098 A SE 0004098A SE 0004098 D0 SE0004098 D0 SE 0004098D0
Authority
SE
Sweden
Prior art keywords
novel compounds
substituted
triazolo
pyrimidines
medicaments
Prior art date
Application number
SE0004098A
Other languages
English (en)
Inventor
Simon Guile
Barrie Martin
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0004098A priority Critical patent/SE0004098D0/sv
Publication of SE0004098D0 publication Critical patent/SE0004098D0/sv
Priority to JP2002541103A priority patent/JP4190282B2/ja
Priority to US10/399,748 priority patent/US6844348B2/en
Priority to AT01981286T priority patent/ATE339420T1/de
Priority to AU2002212941A priority patent/AU2002212941A1/en
Priority to ES01981286T priority patent/ES2271083T3/es
Priority to EP01981286A priority patent/EP1335918B1/en
Priority to PCT/SE2001/002472 priority patent/WO2002038571A1/en
Priority to DE60123103T priority patent/DE60123103T2/de
Priority to HK03108712A priority patent/HK1056361A1/xx
Priority to US11/008,895 priority patent/US7345047B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
SE0004098A 2000-11-09 2000-11-09 Novel compounds SE0004098D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE0004098A SE0004098D0 (sv) 2000-11-09 2000-11-09 Novel compounds
DE60123103T DE60123103T2 (de) 2000-11-09 2001-11-07 Neue verbindungen
AU2002212941A AU2002212941A1 (en) 2000-11-09 2001-11-07 Novel compounds
US10/399,748 US6844348B2 (en) 2000-11-09 2001-11-07 2,3,4-cyclopentan-2,3,4-triol-1-yl compounds
AT01981286T ATE339420T1 (de) 2000-11-09 2001-11-07 Neue verbindungen
JP2002541103A JP4190282B2 (ja) 2000-11-09 2001-11-07 新規化合物
ES01981286T ES2271083T3 (es) 2000-11-09 2001-11-07 Nuevos compuestos.
EP01981286A EP1335918B1 (en) 2000-11-09 2001-11-07 Novel compounds
PCT/SE2001/002472 WO2002038571A1 (en) 2000-11-09 2001-11-07 Novel compounds
HK03108712A HK1056361A1 (en) 2000-11-09 2003-11-28 Novel compounds
US11/008,895 US7345047B2 (en) 2000-11-09 2004-12-10 Substituted [1,2,3]triazolo[4,5-d]pyrimidines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004098A SE0004098D0 (sv) 2000-11-09 2000-11-09 Novel compounds

Publications (1)

Publication Number Publication Date
SE0004098D0 true SE0004098D0 (sv) 2000-11-09

Family

ID=20281755

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0004098A SE0004098D0 (sv) 2000-11-09 2000-11-09 Novel compounds

Country Status (10)

Country Link
US (2) US6844348B2 (sv)
EP (1) EP1335918B1 (sv)
JP (1) JP4190282B2 (sv)
AT (1) ATE339420T1 (sv)
AU (1) AU2002212941A1 (sv)
DE (1) DE60123103T2 (sv)
ES (1) ES2271083T3 (sv)
HK (1) HK1056361A1 (sv)
SE (1) SE0004098D0 (sv)
WO (1) WO2002038571A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004107A1 (en) * 2004-07-02 2006-01-05 Masanori Ojima Method for designing a pharmaceutical compound specific to a desired receptor, a designed compound thereby, and pharmaceutical compositions containing the same
DE102008002471A1 (de) * 2008-06-17 2009-12-24 Biotronik Vi Patent Ag Stent mit einer Beschichtung oder einem Grundkörper, der ein Lithiumsalz enthält, und Verwendung von Lithiumsalzen zur Restenoseprophylaxe
CN102653539B (zh) * 2011-03-01 2014-09-17 秦引林 一种抗血小板聚集化合物及其药物组合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017014A1 (es) * 1997-07-22 2001-08-22 Astrazeneca Ab Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos

Also Published As

Publication number Publication date
ES2271083T3 (es) 2007-04-16
US20050143399A1 (en) 2005-06-30
ATE339420T1 (de) 2006-10-15
JP2004513173A (ja) 2004-04-30
US7345047B2 (en) 2008-03-18
JP4190282B2 (ja) 2008-12-03
EP1335918A1 (en) 2003-08-20
DE60123103D1 (de) 2006-10-26
HK1056361A1 (en) 2004-02-13
DE60123103T2 (de) 2007-03-15
AU2002212941A1 (en) 2002-05-21
WO2002038571A1 (en) 2002-05-16
US20040029899A1 (en) 2004-02-12
EP1335918B1 (en) 2006-09-13
US6844348B2 (en) 2005-01-18

Similar Documents

Publication Publication Date Title
TR200000197T2 (tr) Yeni bileşimler
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
CY1113047T1 (el) Νεα κρυσταλλικη και αμορφη μορφη μιας ενωσης τριαζολο (4,5-d) πυριμιδινης
WO2003095455A3 (en) Substituted pyrazolopyrimidines
SE9702772D0 (sv) Novel compounds
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
AU2002341920A1 (en) Chemical compounds
WO2004074244A3 (en) Pyrimidine compounds
WO2002048147A3 (en) Pyrazolopyridines
SE9802729D0 (sv) Novel Compounds
TR200000152T2 (tr) Yeni bileşikler.
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
MXPA02012493A (es) 1-aril-4-oxo, 1,4-dihidro-3-quinolincarboxamidas como agentes antivirales.
WO2004075846A3 (en) Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
ATE251162T1 (de) Triazolo(4,5-d)pyrimidin-verbindungen
MXPA04001773A (es) Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos.
SE9904128D0 (sv) Novel compounds
SE0004098D0 (sv) Novel compounds
HUP0303486A3 (en) Compositions containing 3,7-diazabicyclo [3,3,1] compounds as anti-arrythmic compounds agents
HK1056362A1 (en) Triazolo Ä4,5-dÜ pyrimidine derivatives as anti-thrombotic agents
EP1436279B8 (en) Chemical compounds
HRP20050790A2 (en) New combinations and new use of selected pharmaceutically active compounds